Phosphodiesterase 4 inhibition as a novel treatment for stroke
The incidence of stroke ranks third among the leading causes of mortality worldwide. It has the characteristics of high morbidity, high disability rate and high recurrence rate. The current risk associated with stroke surgery is exceedingly high. It may potentially outweigh the benefits and fail to...
Saved in:
Main Authors: | Jiahong Zhong, Xihui Yu, Zhuomiao Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2025-01-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/18905.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of phosphodiesterase 4B in IL-8/LTB4-induced human neutrophil chemotaxis evaluated with a phosphodiesterase 4B inhibitor
by: Suzuki Osamu, et al.
Published: (2015-06-01) -
Exploring the Therapeutic Landscape: A Narrative Review on Topical and Oral Phosphodiesterase-4 Inhibitors in Dermatology
by: Elena Carmona-Rocha, et al.
Published: (2025-01-01) -
Modulation of Second Messenger Signaling in the Brain Through PDE4 and PDE5 Inhibition: Therapeutic Implications for Neurological Disorders
by: Min Kyu Park, et al.
Published: (2025-01-01) -
Cardiac Gene Therapy With Phosphodiesterase 2A Limits Remodeling and Arrhythmias in Mouse Models of Heart Failure
by: Rima Kamel, et al.
Published: (2025-02-01) -
Mechanisms of L-citrulline on phosphodiesterase 5 in erectile dysfunction intervention
by: Abdulhakeem Olarewaju Sulyman, et al.
Published: (2025-03-01)